Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma, Kaposi 2HIV Infections 2Acquired Immunodeficiency Syndrome 2Lymphoma 1

Interventions

Zidovudine 9Interferon alpha-2 5Doxorubicin 5Vincristine 4Bleomycin 4pomalidomide 3Specimen Handling 3Nivolumab 3Magnetic Resonance Spectroscopy 3sargramostim 2liposomal doxorubicin 2interferon alfa-n1 2Etoposide 2Didanosine 2Biopsy 2Bevacizumab 2tocilizumab 1pembrolizumab 1halofuginone 1entinostat 1cabozantinib 1abemaciclib 1Zalcitabine 1Valganciclovir 1Therapeutics 1Sorafenib 1Psychiatric Rehabilitation 1Paclitaxel 1O-(Chloroacetylcarbamoyl)fumagillol 1Nicotine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Sarcoma, Kaposi × Didanosine × Clear all
NCT00001114 2021-11-01

The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
90 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00000954 2021-10-29

A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
72 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡